ClinChoice · 1 day ago
Manager, Statistical Programmer Consultant-Remote
Maximize your interview chances
BiotechnologyConsulting
Insider Connection @ClinChoice
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Work directly for a single sponsor while leveraging the security of a global CRO.
Establish a high-trust environment with the client's counterparts.
Effectively plan, control, and carry on tasks in SAS programming, statistical analysis, and submission of trial data and results to regulatory agencies.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
M.Sc., or higher degree in Statistics, Biostatistics, Computer Science, or relevant fields.
Minimum 9 years' experience with in-depth knowledge of clinical trial data processing and manipulation, hands on statistical programming and analysis, requirements for assembling and presenting trial results to regulatory agencies.
Knowledge of industry standards on how clinical trial data are structured, stored, analyzed, and presented.
Knowledge of clinical trial regulatory and ICH requirements.
Must demonstrate ability to effectively plan, control, and carry on tasks in SAS programming, statistical analysis, and submission of trial data and results to regulatory agencies.
Must possess in-depth level understanding of the concept of standardization in data, programming, and statistical reporting of trial results, and its implication to the relevant functions and operations.
Must have sound technical judgment and experience in process design and implementation in relevant areas.
Strong leadership and drive to achieve goals will be required.
Company
ClinChoice
ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide.
Funding
Current Stage
Late StageTotal Funding
$212MKey Investors
Legend CapitalGoldman Sachs
2022-07-04Series E· $150M
2019-10-25Series D· $62M
2019-05-01Series C
Recent News
2023-07-18
Bloomberg.com
2023-07-07
2023-03-02
Company data provided by crunchbase